Global Influenza Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431677
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astrazeneca PLC
  • Chiron Corporation
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • MORE
Influenza Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Influenza therapeutics market was valued at US$ 6001.2 Mn in 2016, and is expected to reach US$ 1204.1 Mn by 2025, expanding at a CAGR of 7.8% from 2017 to 2025.

Market Insights

Global influenza market will grow significantly during forecast period due to growing incidence of influenza worldwide, government initiatives in awareness and diagnostic programs are primarily driving the growth of influenza therapeutics market globally. For the purpose of study market is segmented on the basis of therapy type such as vaccines (trivalent and quadrivalent) and drugs (zanamivir, oseltamivir, peramivir and other). Currently, influenza vaccines (also known as flu shots or jabs) dominating the global influenza market because government initiative for vaccination is prime factor that driving the growth of influenza vaccine market globally; The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), The European Centre for Disease Prevention and Control recommends yearly vaccination for nearly all people over the age of six months, especially those at high risk. In the base year 2016, North America held largest share in global influenza therapeutics market; it is observed that, United States is largest regional market in North America due to factors such as upsurge funding by government, increase in incidence of disease and higher number of geriatric population are driving the market growth in United States. The US government awarded 5 year contracts for more than $1 billion to five drug manufacturers developing technology for speedier mass production of vaccines, it includes GlaxoSmithKline, Medimmune Inc. Novartis Vaccines and Diagnostics, DynPort Vaccine Company, LLC. and Solvay Pharmaceuticals, these all factors are fueling the growth of influenza therapeutics market worldwide.

Market Competition Assessment

The influenza therapeutics market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Abbott Laboratories, Astrazeneca PLC., Biocryst Pharmaceuticals, Inc., Chiron Corporation, CSL Limited, Daiichi Sankyo Co., Ltd., Glaxosmithkline PLC., Mitsubishi Tanabe Pharma Corporation, Nanotherapeutics Inc., Protein Sciences Corporation, Roche Holding AG, Sanofi SA, Shionogi & Co., Ltd., Sinovac Biotech Ltd. and other.

Key Market Movements:
  • Factors such as rising incidence of influenza, growing geriatric population and upsurge funding by the government for treatment expected to drive the growth of influenza therapeutics market during forecast period.
  • However, some factors such as lower healthcare awareness in some developing countries may negatively impacting the growth of influenza therapeutics market globally.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astrazeneca PLC
  • Chiron Corporation
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Influenza Therapeutics Market Snapshot
2.2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
2.3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)

Chapter 3 Influenza Therapeutics Market Analysis
3.1 Global Influenza Therapeutics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in prevalence of Influenza
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Pipeline Analysis
3.4 Attractive Investment Proposition
3.5 Competitive Landscape of Key Players in Influenza Market

Chapter 4 Global Influenza Therapeutics Market, by Therapy Type
4.1 Overview
4.3 Vaccines
4.4 Drugs

Chapter 5 Global Influenza Therapeutics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Astrazeneca PLC
6.3 Biocryst Pharmaceuticals, Inc.
6.4 Chiron Corporation
6.5 CSL Limited
6.6 Daiichi Sankyo Co., Ltd.
6.7 Glaxosmithkline PLC
6.8 Mitsubishi Tanabe Pharma Corporation
6.9 Nanotherapeutics Inc.
6.10 Protein Sciences Corporation
6.11 Roche Holding AG
6.12 Sanofi SA
6.13 Shionogi & Co., Ltd.
6.14 Sinovac Biotech Ltd.

List of Figures
Fig. 1 Influenza Therapeutics Market: Research Methodology
Fig. 2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
Fig. 3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Influenza Therapeutics Market, by Geography, 2016
Fig. 5 Global Vaccines Market for Influenza Therapeutics, 2015 - 2025 (US$ Mn)
Fig. 6 Global Drugs Market for Influenza Therapeutics, 2015 - 2025 (US$ Mn)
Fig. 7 Latin America Influenza Therapeutics Market, 2015 - 2025 (US$ Mn)
Fig. 8 Middle East and Africa Influenza Therapeutics Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Market Positioning of Key Players in Global Influenza Therapeutics Market
Table 2 Global Influenza Therapeutics Market, by Therapy Type, 2015 - 2025 (US$ Mn)
Table 3 Global Influenza Therapeutics Market, by Geography, 2015 - 2025 (US$ Mn)
Table 4 North America Influenza Therapeutics Market, 2015 - 2025 (US$ Mn)
Table 5 Europe Influenza Therapeutics Market, 2015 - 2025 (US$ Mn)
Table 6 Asia Pacific Influenza Therapeutics Market, 2015 - 2025 (US$ Mn)
Table 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 8 Astrazeneca PLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 Biocryst Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Chiron Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 CSL Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Daiichi Sankyo Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Glaxosmithkline PLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Mitsubishi Tanabe Pharma Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Nanotherapeutics Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Protein Sciences Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Roche Holding AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Sanofi SA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Shionogi & Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 20 Sinovac Biotech Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Astrazeneca PLC
  • Biocryst Pharmaceuticals, Inc.
  • Chiron Corporation
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • Mitsubishi Tanabe Pharma Corporation
  • Nanotherapeutics Inc.
  • Protein Sciences Corpora
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll